I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Piccart, Martine J.
717
results:
english X
Search for persons
X
Format
Online (716)
Print (1)
Mediatypes
E-Books (2)
Articles (Online) (304)
Articles (Print) (1)
OpenAccess-fulltext (410)
Sorted by: Relevance
Sorted by: Year
?
1
Progression-free survival assessment by local investigators..:
Jacobs, Flavia
;
Molinelli, Chiara
;
Martins-Branco, Diogo
...
European Journal of Cancer. 197 (2024) - p. 113478 , 2024
Link:
https://doi.org/10.1016/..
?
2
Author Correction: Safety analyses from the phase 3 ASCENT ..:
Rugo, Hope S.
;
Tolaney, Sara M.
;
Loirat, Delphine
...
npj Breast Cancer. 10 (2024) 1 - p. , 2024
Link:
https://doi.org/10.1038/..
?
3
Emerging treatments in HER2-positive advanced breast cancer..:
Agostinetto, Elisa
;
Curigliano, Giuseppe
;
Piccart, Martine
Cell Reports Medicine. 5 (2024) 6 - p. 101575 , 2024
Link:
https://doi.org/10.1016/..
?
4
Tailoring neo/adjuvant systemic therapy in breast cancer: "..:
Elghazaly, Hesham
;
Azim, Hamdy A.
;
Rugo, Hope S.
...
Cancer. , 2024
Link:
https://doi.org/10.1002/..
?
5
Tailoring the optimal duration of the extended adjuvant end..:
Pala, Laura
;
De Pas, Tommaso
;
Pagan, Eleonora
...
The Breast. 69 (2023) - p. 258-264 , 2023
Link:
https://doi.org/10.1016/..
?
6
PB2707: ESMO-MAGNITUDE OF CLINICAL BENEFIT SCALE FOR HAEMAT..:
Kiesewetter, Barbara
;
Dafni, Urania
;
de Vries, Elisabeth G E
...
HemaSphere. 7 (2023) S3 - p. e02308e3 , 2023
Link:
https://doi.org/10.1097/..
?
7
International research to address the challenges of metasta..:
Caballero, Carmela
;
Irrthum, Alexandre
;
Goulioti, Theodora
...
npj Breast Cancer. 9 (2023) 1 - p. , 2023
Link:
https://doi.org/10.1038/..
?
8
Real-world clinical outcomes of patients with stage I HER2-..:
Debien, Veronique
;
Marta, Guilherme Nader
;
Agostinetto, Elisa
...
Critical Reviews in Oncology/Hematology. 190 (2023) - p. 104089 , 2023
Link:
https://doi.org/10.1016/..
?
9
Anthracycline-containing and taxane-containing chemotherapy..:
Braybrooke, Jeremy
;
Bradley, Rosie
;
Gray, Richard
...
The Lancet. 401 (2023) 10384 - p. 1277-1292 , 2023
Link:
https://doi.org/10.1016/..
?
10
Immunological and clinicopathological features predict HER2..:
Rediti, Mattia
;
Fernandez-Martinez, Aranzazu
;
Venet, David
...
Nature Communications. 14 (2023) 1 - p. , 2023
Link:
https://doi.org/10.1038/..
?
11
Obesity-associated changes in molecular biology of primary ..:
Nguyen, Ha-Linh
;
Geukens, Tatjana
;
Maetens, Marion
...
Nature Communications. 14 (2023) 1 - p. , 2023
Link:
https://doi.org/10.1038/..
?
12
Ten-year survival of neoadjuvant dual HER2 blockade in pati..:
Nuciforo, Paolo
;
Townend, John
;
Piccart, Martine J.
...
European Journal of Cancer. 181 (2023) - p. 92-101 , 2023
Link:
https://doi.org/10.1016/..
?
13
Health-related quality of life in the phase III ASCENT tria..:
Loibl, Sibylle
;
Loirat, Delphine
;
Tolaney, Sara M.
...
European Journal of Cancer. 178 (2023) - p. 23-33 , 2023
Link:
https://doi.org/10.1016/..
?
14
Safety analyses from the phase 3 ASCENT trial of sacituzuma..:
Rugo, Hope S.
;
Tolaney, Sara M.
;
Loirat, Delphine
...
npj Breast Cancer. 8 (2022) 1 - p. , 2022
Link:
https://doi.org/10.1038/..
?
15
Sacituzumab govitecan as second-line treatment for metastat..:
Carey, Lisa A.
;
Loirat, Delphine
;
Punie, Kevin
...
npj Breast Cancer. 8 (2022) 1 - p. , 2022
Link:
https://doi.org/10.1038/..
1-15